DIPHENYLHYDANTOIN AS AN ANTICONVULSANT: EVALUATION OF TREATMENT IN FORTY MENTALLY. SUBNORMAL EPILEPTICS*
- 28 June 2008
- journal article
- clinical trial
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 13 (3), 212-218
- https://doi.org/10.1111/j.1365-2788.1969.tb01084.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Management of Epilepsy With Diphenylhydantoin SodiumPublished by American Medical Association (AMA) ,1968
- SOURCES OF ERROR IN THE DETERMINATION OF PHENYTOIN (DILANTIN®) BY SVENSMARK & KRISTENSEN'S METHODActa Neurologica Scandinavica, 1967
- THE METABOLIC CONVERSION OF PRIMIDONE (MYSOLINE®) TO PHENOBARBITONE IN PATIENTS UNDER LONG-TERM TREATMENTActa Neurologica Scandinavica, 1967
- The estimation of some important anticonvulsant drugs in serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Relative Anticonvulsant Potency of PrimidoneArchives of Neurology, 1966
- Drug interactions in manClinical Pharmacology & Therapeutics, 1965
- Clinical pharmacology of anticonvulsant compoundsClinical Pharmacology & Therapeutics, 1961
- Dilantin toxicityNeurology, 1961
- Clinical and Electroencephalographic Correlations with Serum Levels of DiphenylhydantoinArchives of Neurology, 1960
- SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERSJAMA, 1938